This article is more than 5 years old. Information may no longer be current.
Patients report high satisfaction rate in FDA LASIK outcomes questionnaire
Click Here to Manage Email Alerts
After nearly 2 decades of clinical application in the U.S., LASIK has achieved high success and satisfaction rates. Many surgeons and patients attest to positive visual outcomes from LASIK, and LASIK has seen a recent uptick in patients choosing to undergo the procedure.
Data presented at the American Academy of Ophthalmology meeting in Chicago shed new light on patient-reported LASIK outcomes. Some experts believe the study, performed in response to reports of post-LASIK visual symptoms, speaks to the procedure’s safety and efficacy.
PROWL-1 and PROWL-2, part of the U.S. Food and Drug Administration’s LASIK Quality of Life Collaboration Project presented by Malvina B. Eydelman, MD, showed that overall the prevalence of visual symptoms, such as ghosting, glare, halos and starbursts, did not increase in patients undergoing LASIK.
The U.S. Trends in Refractive Surgery: 2014 ISRS Survey, presented at the AAO meeting by Richard J. Duffey, MD, showed that LASIK began to rebound in 2014 after a decade-long decline that Duffey attributed to the economic recession and publicized reports of poor outcomes and visual symptoms.
Kerry D. Solomon, MD, OSN Refractive Surgery Board Member, described the FDA study results as “very reassuring.”
Click here to read the cover story published in Ocular Surgery News U.S. Edition, January 25, 2015.